メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
医学部・先端ロボット・内視鏡手術学
藤田医科大学
医学部
概要
フィンガープリント
ネットワーク
プロファイル
(6)
研究成果
(64)
フィンガープリント
医学部・先端ロボット・内視鏡手術学が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Abdominal Cancer
12%
Adenocarcinoma
18%
Adjuvant Chemotherapy
14%
Advanced Cancer
7%
Adverse Event
6%
Anal Fistula
11%
Appendectomy
11%
Biopsy
16%
Bleeding
34%
Cancer
11%
Cancer Surgery
35%
Carcinoma
12%
Chemoradiotherapy
27%
Chylothorax
11%
Cisplatin
6%
Clinical Feature
11%
Clinical Stage
8%
Cohort Analysis
12%
Colectomy
14%
Colon Cancer
14%
Colon Motility
11%
Colorectal Cancer
12%
Colorectal Carcinoma
11%
Conversion Therapy
11%
Crohn's Disease
11%
Da Vinci Surgical System
28%
Daikenchuto
11%
Debridement
5%
Disease
11%
Distal Pancreatectomy
11%
Empyema
11%
Endoscopic Surgery
11%
Endoscopic Ultrasound
7%
Esophageal Cancer
11%
Esophagectomy
11%
Esophagus
11%
First-Line Chemotherapy
5%
Fistula
16%
Fluorouracil
8%
FOLFIRI
11%
Gastrectomy
68%
Gastroesophageal Junction
11%
Gastrointestinal Stromal Tumor
38%
Granular Cell Tumor
11%
Hazard Ratio
13%
Hepatectomy
16%
Imatinib
22%
Incision
11%
Intestine Cancer
11%
Kocher Manoeuvre
11%
Laparoscopic Surgery
21%
Laparoscopy
37%
Leiomyosarcoma
11%
Lipiodol
5%
Liver Arteriography
11%
Liver Metastasis
22%
Local Excision
8%
Logistic Regression Analysis
7%
Lung Surgery
5%
Lymph Node
25%
Lymph Node Metastasis
33%
Lymphangiography
11%
Magnetic Resonance Imaging
7%
Malignant Neoplasm
18%
Metastatic Carcinoma
27%
Multimodality Cancer Therapy
11%
Neoadjuvant Therapy
14%
Neoplasm
91%
Operation Duration
7%
Pancreas Cancer
11%
Paraaortic Lymph Node
13%
Perianal Abscess
11%
Postoperative Complication
23%
Preoperative Chemotherapy
6%
Propensity Score Matching
14%
Prospective Study
13%
Radiation Therapy
17%
Rectum Cancer
100%
Rectum Resection
7%
Rectum Surgery
11%
Recurrent Disease
58%
Retroperitoneal Lymph Node Dissection
19%
Retrospective Study
33%
Robot-Assisted Surgery
37%
Sigmoid Cancer
14%
Squamous Cell Carcinoma
11%
Stenting
11%
Stomach Cancer
53%
Stomach Surgery
11%
Superior Mesenteric Artery
11%
Surgeon
23%
Surgery
42%
Surgical Anastomosis
6%
Surgical Margin
21%
Thorax Surgery
11%
Total Stomach Resection
5%
Tumor Recurrence
6%
Ulcerative Colitis
11%
Upper Gastrointestinal Surgery
11%
Venous Ulcer
5%
Keyphrases
Adjuvant Chemotherapy
16%
After Surgery
11%
Anal Squamous Cell Carcinoma
22%
Blood Loss
10%
Cancer-related
11%
Carcinoma Associated with Anal Fistula
11%
Chemoradiotherapy
11%
Chemotherapy
18%
Cisplatin Delivery
11%
Clinical Experience
11%
Clinical Features
11%
Colon Cancer Patients
11%
Colorectal Cancer
39%
Colorectal Cancer Patients
11%
Confidence Interval
9%
Conversion Surgery
11%
Conversion Therapy
11%
Crohn's Disease
11%
CT during Hepatic Arteriography
11%
Curative Resection
11%
Curative Surgery
16%
Da Vinci Surgical System
14%
Da Vinci Xi System
12%
Duodenal Gastrointestinal Stromal Tumors
11%
Endoscopic Surgical Skill Qualification System
11%
Esophageal Stenting
11%
Esophagorespiratory Fistula
11%
Expert Survey
11%
First-line Chemotherapy
5%
FOLFIRI
11%
FOLFIRINOX
11%
Gastric Bypass Surgery
11%
Gastric Cancer
22%
Gastric Cancer with Liver Metastasis
11%
Gastrointestinal Stromal Tumor
11%
Hazard Ratio
9%
High Risk
12%
Hinotori
11%
Histological Remission
11%
Intestinal Cancer
11%
Japan
9%
Japanese Population
11%
Kocher Maneuver
11%
Laparoscopy-assisted Gastrectomy
11%
Lateral Lymph Node Metastasis
11%
Leiomyosarcoma
11%
Leonardo Da Vinci
18%
Lipiodol Lymphangiography
7%
Liver Surface
7%
Local Gastrectomy
11%
Low Rectal Cancer
11%
Lung
11%
Lymph Node
6%
Lymph Node Metastasis
11%
Margin Quality
11%
Median Arcuate Ligament
11%
Minimally Invasive Distal Pancreatectomy
11%
Moving on
11%
Multidisciplinary Therapy
11%
Near-infrared Photoimmunotherapy (NIR-PIT)
11%
Neoadjuvant Chemoradiotherapy (nCRT)
11%
Neoadjuvant Therapy
11%
Older Men
9%
Oncological Outcomes
11%
Para-aortic Lymph Node Metastasis
11%
Perianal Lesion
8%
Postoperative Course
9%
Postoperative Follow-up
11%
Progressive Disease
5%
Propensity Score Analysis
11%
R0 Resection
12%
Radiation Therapy
11%
Rectal Carcinoma
11%
Rehepatectomy
11%
Resectable Pancreatic Cancer
11%
Resection
11%
Retrospective Analysis
11%
Robot-assisted Surgery
22%
Robotic Distal Gastrectomy
16%
Robotic Gastrectomy
11%
Robotic Rectal Surgery
11%
Robotic Surgery
12%
S-system
11%
Short-term Outcomes
11%
Single-center Retrospective Study
22%
Single-incision Laparoscopy
11%
Skip Metastasis
11%
Stable Disease
11%
Staging Laparoscopy
7%
Stomach
16%
Superior Mesenteric Artery
11%
Superior Rectal Artery
7%
Surgical Robot
12%
TME Quality
11%
Treatment Outcome
11%
Tumor
27%
Ulcerative Colitis
11%
Umbilical Port
11%
X-ray Study
7%
Young Males
7%